Gout & crystal arthritis

Prospective 12-month ultrasound evaluation of carotid atherosclerosis, urate deposits, and musculoskeletal inflammation in newly diagnosed gout

Clin Exp RheumatolPublished Prospective cohort study

Authors' conclusion

After 12 months of urate-lowering treatment, the absence of musculoskeletal inflammation at ultrasound in gout patients was closely linked to improvements in carotid atheromatous plaques.

Study context

Population
Consecutive patients with crystal-proven gout starting ULT, rheumatology unit78 underwent M12
Participants
103 patients
Exposure
Absent vs persistent power Doppler (PD) signal in relation to carotid plaque changes
Outcome
Association between changes in carotid arteries (increased intima-media thickness, atheromatous plaques), urate deposits and PD signal on US
Follow-up
M0-M6 and M6-M12
Methodological detailssingle-centre, observational, consecutive patients, 91 (88.3%) underwent M6 and 78 (75.7%) M12 evaluations, near of 97% received ULT; almost half used lipid-lowering drugs
  • Single-centre
  • Observational
  • Consecutive patients
  • 91 (88.3%) underwent M6 and 78 (75.7%) M12 evaluations
  • Near of 97% received ULT; almost half used lipid-lowering drugs

Main finding

As reported in the abstract

Carotid plaque regression · M12

P = 0.017

Observational data: associations, not effects.

Further findings

Carotid vs musculoskeletal changes · M6

No association between changes in carotid and musculoskeletal variables

Baseline US findings · M0

Mean number of locations with deposits
9.9 (SD 4.1)
Mean number of locations with positive PD signal
1.1 (SD 1.1)
Carotid atheromatous plaque
59%

Original publication

Prospective 12-month ultrasound evaluation of carotid atherosclerosis, urate deposits, and musculoskeletal inflammation in newly diagnosed gout. Clin Exp Rheumatol. Published 18 November 2025. doi:10.55563/clinexprheumatol/od8dfn

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.